Blogs Recent News

Latest News

What We Are Up To

Diverse Biotech Announces Its DBT-12733 Molecule Demonstrated to Be Up to 8,000 Times More Effective Than Temozolomide for Brain Cancer

  • Tue Oct 26
  • Array
  • 0

Diverse Biotech Announces New Patent Approval for Its PEMBROLIZUMAB Antibody Drug DBT-50201

  • Wed Aug 30
  • Array
  • 0